OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Myriad Genetics/  US62855J1043  /

IEX
2024-05-03  9:59:59 PM Chg. +0.23 Volume Bid- Ask- High Low
19.45USD +1.20% 17,417
Turnover: 341,006.87		 -Bid Size: - -Ask Size: - 20.07 19.41
GlobeNewswire 04-30 Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
GlobeNewswire 04-17 Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According t...
GlobeNewswire 04-16 New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 2...
GlobeNewswire 04-09 Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after Gene...
GlobeNewswire 04-05 Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry
GlobeNewswire 03-22 Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Earl...
GlobeNewswire 03-20 Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
GlobeNewswire 03-13 BioHive to launch HealthTech Hub Chapter to Empower Medical Innovation and Disrupt Healthcare
GlobeNewswire 02-27 Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Result...
GlobeNewswire 02-27 Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter R...
GlobeNewswire 02-27 Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Moni...
GlobeNewswire 02-21 Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
GlobeNewswire 02-15 Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Healt...
GlobeNewswire 02-01 Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermoun...
GlobeNewswire 01-30 Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
GlobeNewswire 01-19 Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision...
GlobeNewswire 01-09 Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SS...
GlobeNewswire 01-08 Mesa Laboratories Appoints Mark Capone to its Board of Directors
GlobeNewswire 01-03 Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-12-21 Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor...
GlobeNewswire 2023-12-20 Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care
GlobeNewswire 2023-11-20 Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents
GlobeNewswire 2023-11-16 Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
GlobeNewswire 2023-11-09 Myriad Genetics to Participate in Stephens Annual Investment Conference
GlobeNewswire 2023-11-09 Myriad Genetics Announces Pricing of Upsized Offering of Common Stock